<DOC>
	<DOCNO>NCT00833781</DOCNO>
	<brief_summary>The purpose study find whether experimental autologous dendritic cell vaccine safe , well tolerate , whether strengthen immune system 's response HIV .</brief_summary>
	<brief_title>A Pilot Study Dendritic Cell Vaccine HIV-1 Infected Subjects</brief_title>
	<detailed_description>This randomized trial evaluate whether mRNA-transfected dendritic cell vaccination safe immunogenic HIV-infected participant antiretroviral therapy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV1 positive CD4+ T Cell count &gt; 200 Undetectable HIV viral load 6 month prior screen On antiretroviral treatment 12 month prior screen Hepatitis C positive Detectable HIV viral load within 6 month prior study entry Females pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV vaccine</keyword>
	<keyword>Dendritic cell</keyword>
	<keyword>treatment experience</keyword>
</DOC>